Actavis Eyes Acquisitions In The Middle East And Niche Products In The U.S.
This article was originally published in The Pink Sheet Daily
Executive Summary
The company's new CEO, Claudio Albrecht, is gearing up for growth by looking to acquire BioPartners, a biosimlars opportunity, but also on his radar are geographic expansion in Asia and the Middle East, and development of modified-release products.